📄 "NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma" . EBV ( May 14, 2026 at 08:09PM)
https://pubmed.ncbi.nlm.nih.gov/42133805/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260514190911&v=2.20.0

📄 "Epstein-Barr virus-encoded microRNAs: central players in nasopharyngeal and gastric carcinoma pathogenesis" . Vírus e Câncer ( May 17, 2026 at 10:37AM)
https://pubmed.ncbi.nlm.nih.gov/42143203/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260517093708&v=2.20.0

📄 "Epstein-Barr virus associated diseases: Immune alterations and targeted approaches" . EBV ( May 25, 2026 at 04:07PM)
https://pubmed.ncbi.nlm.nih.gov/42183201/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260525150757&v=2.20.0

📄 "A Host miRNA Signature Correlates With Clinical Stage Across Epstein-Barr Virus-Associated Malignancies" . EBV ( May 27, 2026 at 08:38AM)
https://pubmed.ncbi.nlm.nih.gov/42198896/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260527073827&v=2.20.0

📄 "CD80 (B7-1) as a potential therapeutic target in Epstein-Barr virus-associated B cell diseases" . EBV ( May 27, 2026 at 04:38AM)
https://pubmed.ncbi.nlm.nih.gov/42191836/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260527033816&v=2.20.0

📄 "Epstein-Barr virus (EBV) infection causes human germinal center B cell-derived lymphomas in the absence of EBNA2 expression" . EBV ( May 27, 2026 at 12:59AM)
https://pubmed.ncbi.nlm.nih.gov/42189985/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260526235942&v=2.20.0

📄 "Epstein-Barr virus reprograms immune escape in nasopharyngeal carcinoma" . Vírus e Câncer ( May 26, 2026 at 09:45PM)
https://pubmed.ncbi.nlm.nih.gov/42186960/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260526204508&v=2.20.0

📄 "Epstein-Barr Virus Infection" . EBV ( May 20, 2026 at 05:42AM)
https://pubmed.ncbi.nlm.nih.gov/42156044/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260520044209&v=2.20.0

📄 "Immune Reprogramming by EBV and KSHV in the Tumour Microenvironment: From Mechanisms of Immune Escape to Immunotherapy" . KSHV/HHV-8 ( May 27, 2026 at 10:11PM)
https://pubmed.ncbi.nlm.nih.gov/42202101/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0MbwdG8oCHuS3zShObm9OxM2igUrv8WmS1-6Xt5ghCU&fc=None&ff=20260527211145&v=2.20.0

📄 "Correction to 'HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway'" . KSHV K1 ( June 2, 2026 at 06:25PM)
https://pubmed.ncbi.nlm.nih.gov/42227338/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=14CrWYUMC68AdYTXKDd0hh4uLquZLVP4Wi-clNoJ-jtCCuBMuV&fc=None&ff=20260602172501&v=2.20.0

📄 "Epstein-Barr virus-encoded microRNAs: central players in nasopharyngeal and gastric carcinoma pathogenesis" . EBV ( May 17, 2026 at 08:07AM)
https://pubmed.ncbi.nlm.nih.gov/42143203/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260517070736&v=2.20.0

📄 "Epstein-Barr virus receptors: classification, functional mechanisms, and pathogenic implications" . EBV ( May 11, 2026 at 03:36PM)
https://pubmed.ncbi.nlm.nih.gov/42112902/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260511143606&v=2.20.0

📄 "Epstein-Barr virus-associated tumors: commonalities in pathogenesis and the tumor immune microenvironment" . EBV ( May 11, 2026 at 03:36PM)
https://pubmed.ncbi.nlm.nih.gov/42112354/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260511143606&v=2.20.0

📄 "Loss of systemic anti-viral immunity and LMP1-driven suppressive myeloid tumour niches converge to shape the immunobiology of Epstein-Barr virus-positive diffuse large B-cell lymphoma" . EBV ( June 11, 2026 at 11:15AM)
https://pubmed.ncbi.nlm.nih.gov/42271039/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260611101537&v=2.20.0

📄 "JAK2 Degradation by Strebloside Dismantles PD-L1-Mediated Immune Evasion in EBV-Associated Gastric Cancer" . EBV ( June 11, 2026 at 11:15AM)
https://pubmed.ncbi.nlm.nih.gov/42269762/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260611101537&v=2.20.0

📄 "Diagnostic Significance of Circulating EBV-miR-BHRF1-3 and EBV-miR-BART2-5p in Lymphoma A Case-Control Study" . EBV ( June 8, 2026 at 05:17PM)
https://pubmed.ncbi.nlm.nih.gov/42257093/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260608161735&v=2.20.0

📄 "Progress towards an Epstein-Barr virus vaccine" . EBV ( June 8, 2026 at 05:17PM)
https://pubmed.ncbi.nlm.nih.gov/42253055/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260608161735&v=2.20.0

📄 "Circular RNAs in tumor biology and immunology: molecular mechanisms and therapeutic implications" . Mol Cancer ( June 13, 2026 at 08:52AM)
https://pubmed.ncbi.nlm.nih.gov/42286649/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=00QaWMiXFBEMKNV_qHo-KmRhFk2n8N-2OaTrSFg24S6&fc=None&ff=20260613075243&v=2.20.0

📄 "Epstein-Barr Virus in Brain Cancer-Friend or Foe?" . EBV ( June 12, 2026 at 11:47AM)
https://pubmed.ncbi.nlm.nih.gov/42278342/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260612104729&v=2.20.0

📄 "Epstein-Barr Virus MicroRNAs as Key Regulators of Lymphoma Pathogenesis: Immune Evasion Mechanisms and Therapeutic Opportunities" . Vírus e Câncer ( June 29, 2026 at 03:47AM)
https://pubmed.ncbi.nlm.nih.gov/42365855/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260629024738&v=2.20.0

📄 "Epstein-Barr virus-driven immunosuppression in nasopharyngeal carcinoma: a comprehensive review of viral mechanisms, spatial tumor ecosystems, and precision therapeutics" . Vírus e Câncer ( July 2, 2026 at 10:13AM)
https://pubmed.ncbi.nlm.nih.gov/42389513/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260702091326&v=2.20.0